2 recruiting, 1 completed, 1 enrolling by invitation, 1 not yet recruiting. 3 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Interleukin-23: new trials by email Literature Review of Interleukin-23 trials Research Report on Interleukin-23
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia Placebo, IL-23 - Schizophrenia, Schizo Affective Disorder | Phase 4 | Not yet recruiting | University of Maryland, Baltimore | 40 | 2026-09-01 | 2026-05-29 |
| INSIGHT-IBD Pragmatic Study Mirikizumab, Anti-TNF agents, anti-integrin antibodies - Ulcerative Colitis (UC), Crohn Disease (CD) | Phase 4 | Enrolling by invitation | Specialty Networks Research. | 400 | 2026-08-12 | 2026-10-02 |
| Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety Interleukin 23 - Crohn's Disease and Ulcerative Colitis | Phase 4 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 200 | 2025-12-01 | 2026-04-24 |
| Interleukin23 in Systemic Lupus interleukin 23 - Systemic Lupus Erythematosus Related Interstial Lung Disease | Not applicable | Recruiting | Sohag University | 90 | 2025-05-01 | 2024-12-03 |
| Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid Blood sample for dosages of cytokines (IL-17 and IL-23) and of the protease MMP-9 - Bullous Pemphigoid | Completed | CHU de Reims | 120 | 2009-11-01 | 2016-08-30 |
Colitis, Ulcerative (2) · Crohn Disease (2) · Pemphigoid, Bullous (1) · Psychotic Disorders (1) · Schizophrenia (1)
CHU de Reims (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · Sohag University (1) · Specialty Networks Research. (1) · University of Maryland, Baltimore (1)
United States (2) · China (1) · Egypt (1) · France (1)
Casey Chapman, MD (1) · Deanna L Kelly, PharmD, BCPP (1) · Nicholas Lazarou, MPH, MBA (1)